At the end of the National Day, the precision market in the capital market has ushered in a clean stream. On the evening of October 9, Donghua Software announced the announcement of the Software Licensing and Joint Development Agreement with IBM. The two parties will establish a joint team to jointly develop medical data analysis and transformation for precision medicine.
IBM and Donghua Software will launch a three-year precision medical treatment with IBM's technical achievements and intellectual property rights in precision medical research in recent years, as well as the powerful development capabilities of Donghua Software in digital medical application systems. Joint research and development of new technologies to jointly build a precision medical research and analysis platform. This means that the two sides will take advantage of their respective advantages and make breakthroughs in the transformation of medical research results into clinical applications, laying a solid technical foundation for the realization of disease cognition, intelligent medical care and precision medical care in the future. At the same time, through this cooperation with IBM, Donghua Software's technical capabilities in precision medical big data processing will be greatly enhanced, and technical reserves will be made for the "Watson" system for research and development of independent copyrights in the future.
When in January 2015, US President Barack Obama announced the precision medical plan in his State of the Union speech, “precise medical care†became a hot topic covering the whole world, and the medical health industry market was surging, and domestic and foreign pharmaceutical giants rushed to precision medical treatment. According to a research report, the global precision medical market is nearly 60 billion US dollars in 2015. The annual growth rate is expected to be 15% in the next five years, which is 3 to 4 times the overall growth rate of the pharmaceutical industry. In March of this year, the Ministry of Science and Technology held the first national expert meeting on precision medicine strategy and proposed the China Precision Medical Plan. The meeting pointed out that by 2030, China will invest 60 billion yuan in precision medicine, of which 20 billion yuan will be spent by the central government and 40 billion yuan by enterprises and local governments.
The core information of precision medicine is the two levels of “precision†and “medicalâ€, and the scientific and technological means such as big data analysis tools and technology, medical information application system are the premise to ensure “precisionâ€. It is foreseeable that the realization of precision medicine based on technologies such as big data and cognitive computing, and the popularization of personal genetic sequencing are bringing great changes to the global health and medical industry.
Give full play to the advantages, break through the bottleneck, and accurately apply medical data to the blue ocean market.
Although the prospects for precision medicine are good, the process of implementation is extremely complicated. How to accurately collect and integrate large sample information in precision medicine, how to carry out simple and efficient cognitive calculation is the key core high technology and technical problem. In addition, similar classification analysis of patient disease data is another difficulty in implementing precision medicine. Therefore, the complexity of precision medical big data is much higher than the traditional Internet big data.
At present, various medical institutions in China have arranged accurate medical treatments. However, clinical data in various medical institutions still have a data island phenomenon that is inconsistent with each other. There are still many difficulties in the construction of the whole process and complete electronic medical records centered on clinical data, thus forming Insufficient and effective, as well as full-process and complete data samples, these hinder the integration and standardization of precision medicine.
In this collaboration, IBM, known as the "Blue Giant", is now a well-deserved leader in big data processing in the field of precision medicine. IBM combines the advantages of Watson Health with the top domestic medical experts to apply big data processing technology to clinical research, using cognitive computing, big data analysis, cloud computing and other new technologies to form a unique application for medical big data processing. And the technical achievements in analysis make the analysis and processing of medical data more effective, and the results of clinical research are more accurate.
Pain Relief Patch for Breast
[Name] Medical Cold Patch
[Package Dimension] 10 round pieces
The pain relief patch is composed of three layers, namely, backing lining, middle gel and protective film. It is free from pharmacological, immunological or metabolic ingredients.
[Scope of Application] For cold physiotherapy, closed soft tissue only.
[Indications]
The patches give fast acting pain relief for breast hyperplasia, breast fibroids, mastitis, breast agglomera tion, swollen pain.
[How To Use a Patch]
Please follow the Schematic Diagram. One piece, one time.
The curing effect of each piece can last for 6-8 hours.
[Attention]
Do not apply the patch on the problematic skin, such as wounds, eczema, dermatitis,or in the eyes. People allergic to herbs and the pregnant are advised not to use the medication. If swelling or irritation occurs, please stop using and if any of these effects persist or worsen.notify your doctor or pharmacist promptly. Children using the patch must be supervised by adults.
[Storage Conditions]
Store below 30c in a dry place away from heat and direct sunlight.
Pain Relief Patch For Breast,Pain Relief Plaster For Breast,Relief For Breast Pain,Pad Relief Patch For Breast
Shandong XiJieYiTong International Trade Co.,Ltd. , https://www.xjplaster.com